Influenza Market Research Reports & Industry Analysis
Influenza Industry Research & Market Reports
-
Neglected Tropical Diseases Drugs And Vaccines Market Size, Share, and Outlook, 2025 Report- By Disease (Malaria, Ebola, Dengue, Chagas, Leishmaniasis, Zika Virus), By Product (Drugs, Vaccines), 2021-2032
... And Vaccines market is a thriving business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast ... Read More
-
South East Asia Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (HIV, Influenza, HPV, Oncology, Gene Testing), End User - Forecast to 2031
... The Southeast Asia molecular diagnostics market is projected to reach USD 891.9 million by 2031 from an estimated USD 528.3 million in 2024, at a CAGR of 7.8% during the forecast period. Succeeding extensive secondary ... Read More
-
Influenza Vaccines Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Antiviral Drugs Market, By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, and Others), By Type (Branded and Generics), By Application (HIV, Hepatitis, Herpes, Influenza, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... been witnessing steady growth over the past few years. Antiviral drugs, also known as antiviral agents or anti-infective medications, are a class of medication used specifically for treating infections caused by viruses. They work by ... Read More
-
Influenza Vaccines Market, By Vaccine Type (Inactivated, Live Attenuated), By Valency (Quadrivalent, Trivalent), By Route of Administration (Injection, Nasal Spray), By Age Group (Paediatrics, Adults), By Technology (Egg-Based Flu Vaccines, Cell Culture-Based Flu Vaccines, Recombinant Flu Vaccines), By Distribution Channel (Public, Private), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... element of preventive healthcare for decades. The influenza viruses have the ability to mutate and evolve regularly, necessitating the development of updated vaccines each year. The vaccines work to boost the body's immune response to ... Read More
-
Influenza Diagnostics
... CAGR of 5.2% over the analysis period 2024-2030. RIDT Test, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$2.0 Billion by the end of the analysis ... Read More
-
Zika Virus Testing
... at a CAGR of 5.8% over the analysis period 2024-2030. Molecular Testing, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$192.4 Million by the end of ... Read More
-
Influenza Medication
... CAGR of 1.9% over the analysis period 2024-2030. Zanamivir, one of the segments analyzed in the report, is expected to record a 1.2% CAGR and reach US$123.9 Million by the end of the analysis period. ... Read More
-
Influenza Vaccines Global Market Opportunities And Strategies To 2033
... And Institutional Supply5) By Age Group: Pediatric; AdultCovering: Sanofi SA; Seqirus (CSL Limited); GlaxoSmithKline Plc; Daiichi Sankyo Co Ltd; Pfizer Inc Influenza Vaccines Global Market Opportunities And Strategies To 2033 from The Business Research Company ... Read More
-
Influenza Vaccines Market, Persons Vaccinated, By Segment – Vaccine Type, Indication, Technology, Route of Administration, End-user, Geography, Company Analysis - Global Forecast (2025 - 2032)
... 12.16 Billion by 2032, from US$ 7.60 Billion in 2024. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major ... Read More
-
Global Ebola Virus Vaccine Market Growth 2025-2031
... at a CAGR of 6.5% from 2025 to 2031. Ebola vaccine refers to the biological products made from the pathogenic microorganisms of Ebola virus and used to inoculate against Ebola virus. The global pharmaceutical market ... Read More
-
2025 Global: Avian Influenza Vaccines Market - Innovative Markets Forecast (2031) report
... industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market ... Read More
-
2025 Global Forecast for Avian Influenza Vaccines Market (2026-2031 Outlook)-High Tech Outlook Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
mRNA Vaccine and Therapeutics Market by Application Area (Covid-19 and Other Indications), Target Disease Indication (Influenza, Respiratory Syncytial Virus Infection and Cytomegalovirus Diseases) and Geographical Regions (North America, Europe, Asia-Pacific, Latin America and Rest of the World): Industry Trends and Global Forecasts, Till 2035
... the World): Industry Trends and Global Forecasts, Till 2035 mRNA Vaccine And Therapeutics Market: Overview As per Roots Analysis, the global mRNA vaccine and therapeutics market is estimated to be worth USD 1.99 billion by ... Read More
-
Ebola Virus- Competitive Landscape, 2024
... route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Ebola Virus: Understanding Ebola Virus: Overview Ebola is a type of viral hemorrhagic fever caused ... Read More
-
2024-2029 Influenza Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Influenza tests performed in the following market segments: Hospitals Commercial/Private Labs ... Read More
-
Ebola Virus Vaccine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type
... its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, demand, major players, price is presented ... Read More
-
United States Influenza Vaccines Market Report 2025: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2033
... in the United States has experienced significant growth in recent years, driven by various factors including heightened public awareness of infectious diseases and the ongoing innovations in vaccine technology. As of 2024, the market is ... Read More
-
Asia-Pacific qPCR Market Research Report Information by Product & Services (Product & Services), by Application (Clinical, RUO, and Forensic), by Disease Type (Newborn Diseases, Respiratory, STI, Oncology, Gastroenteritis, Tropical Diseases, Herpes Virus Infections, Others), by End User (Hospitals & Clinics, Diagnostic Centers & Laboratories, Pharmaceutical & Biotechnology Companies, Forensic Laboratories, Others) Industry Forecast to 2032
... End User (Hospitals & Clinics, Diagnostic Centers & Laboratories, Pharmaceutical & Biotechnology Companies, Forensic Laboratories, Others) Industry Forecast to 2032 In 2022, the Asia Pacific Blood Glucose Monitoring Market Size was estimated to be USD ... Read More
-
C-X-C Chemokine Receptor 4 (CXCR4) Antagonists Global Market Report 2024 Including: 1) By Type: BL-8040; GMI-1359; Plerixafor (AMD3100); Balixafortide (POL6326); USL311; Burixafor (GPC-100) 2) By Route Of Administration: Oral; Injectable 3) By Product Pipeline: Approved; Clinical Trials; Pre-Clinical 4) By Application: Cancer; Human Immunodeficiency Virus (HIV); Chronic Inflammatory Disease; Stem Cell Mobilization; Immune And Autoimmune Diseases 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies Covering: Pfizer Inc.; F-Hoffmann La Roche Ltd.; Sanofi; Bristol-Myers Squibb Company; AstraZeneca plc
... Pre-Clinical4) By Application: Cancer; Human Immunodeficiency Virus (HIV); Chronic Inflammatory Disease; Stem Cell Mobilization; Immune And Autoimmune Diseases5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online PharmaciesCovering: Pfizer Inc.; F-Hoffmann La Roche Ltd.; Sanofi; Bristol-Myers ... Read More
-
2024 Global Influenza Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Influenza definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the ... Read More
-
2024 Epstein-Barr Virus (EBV) Diagnostics Market: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - US, Europe, Japan - Hospitals, Commercial and Public Health Labs, POC Locations
... detailed analysis of the Epstein-Barr Virus (EBV) diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology are reviewed. The report provides the ... Read More
-
Epstein-Barr Virus: Competitive Landscape
... in the 16 countries covered in GlobalData’s epidemiology forecast. Currently, only one approved product available in the therapeutic market space for EBV and none of the vaccine is currently approved for EBV prophylaxis. R&D activities ... Read More
-
Vaccines Market, By Type (Monovalent Vaccines , Multitvalent Vaccines), By Technology (Conjugate Vaccines, Recombinant Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Other Vaccine Technologies), By Disease Indication (Pneumococcal Disease, Influenza, Combination Vaccines, HPV, Meningococcal Disease, Herpes Zoster, Rotavirus, MMR, Varicella, Hepatitis, DTP, Polio, RSV, Other Disease Indications), By Route of Administration (Intramuscular, Subcutaneous, Oral, Intranasal), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... HPV, Meningococcal Disease, Herpes Zoster, Rotavirus, MMR, Varicella, Hepatitis, DTP, Polio, RSV, Other Disease Indications), By Route of Administration (Intramuscular, Subcutaneous, Oral, Intranasal), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & ... Read More
-
Global Influenza Vaccine Market 2024-2028
... report on the influenza vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
Research Assistance
